Relative efficacy of 5-fluorouracil compared with other treatments among patients with actinic keratosis: A network meta-analysis

Dermatol Ther. 2019 May;32(3):e12822. doi: 10.1111/dth.12822. Epub 2019 Feb 14.

Abstract

Objective: The purpose of this study was to compare the efficacy of 5-fluorouracil (5-FU) with that of other treatments of actinic keratosis (AK).

Methods: A systematic literature review of five databases (including Medline and EMBASE) was first performed to identify randomized controlled trials (RCTs). A network meta-analysis (NMA) based on a random-effects Bayesian model was then performed on the outcomes for patients with total clearance and lesions reduced from baseline. Five treatments (viz., 0.5% 5-FU with 10% salicylic acid [5-FU/SA], 5% 5-FU cream, 3% diclofenac sodium, cryosurgery, and vehicle) were evaluated.

Results: A total of 11 studies involving 2,256 patients with AK were included in this NMA. The overall risk of bias among the included studies was low. All treatments were significantly better than the vehicle both for patients with total clearance and for lesions reduced from baseline. Among patients with total clearance, 5% 5-FU cream (56.8%) and 5-FU/SA (35.7%) were likely to be more effective than the other treatments, whereas 5% 5-FU cream (98.6%) was likely the most effective in the group of lesions reduced from baseline.

Conclusion: 5-FU, diclofenac sodium, and cryosurgery are all useful for AK treatment, with 5-FU being the most effective.

Keywords: 5-fluorouracil; actinic keratosis; diclofenac.

Publication types

  • Comparative Study
  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Administration, Cutaneous
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Cryosurgery / methods
  • Dermatologic Agents / administration & dosage
  • Fluorouracil / administration & dosage*
  • Humans
  • Keratosis, Actinic / drug therapy*
  • Keratosis, Actinic / pathology
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Dermatologic Agents
  • Fluorouracil